Donate

News

Latest news

Multiple Myeloma March tackles low awareness, boosts research

September 30, 2020

New partnership aims to advance predictive tests for multiple myeloma in Ireland

September 21, 2020,

Crohn’s and Colitis NZ patient support group requests your support

September 21, 2020

New myeloma study

September 21, 2020

Drug Exposure, Disease Characteristics Not Linked to Increased Mortality Risk in Patients with Multiple Myeloma Who Contracted COVID-19

September 18, 2020,

Exploring the Future of CAR T-Cell Therapy in Multiple Myeloma

September 18, 2020,

Novel Agents Rouse Responses in Relapsed/Refractory Multiple Myeloma

September 18, 2020,

Despite COVID-19 limitations, fundraiser for multiple myeloma finds a way

September 14, 2020, ,

NICE turns down Celgene’s Revlimid as multiple myeloma maintenance treatment

September 10, 2020,

Blood Cancer Awareness Month

September 7, 2020,

Daratumumab gets PBS listing recommendation after ‘disgraceful’ delay

September 4, 2020,

Newsletter: Spring 2020

August 28, 2020

Learning About Resources in Multiple Myeloma

August 27, 2020,

Changing Patterns of Care in Multiple Myeloma

August 27, 2020,

FDA Approves Daratumumab, Carfilzomib, Dexamethasone Triplet to Treat Multiple Myeloma

August 24, 2020,

COVID-19: Rates of Hospitalization and Mortality Among Patients With Multiple Myeloma

August 20, 2020, ,

Berdeja Compares Later-Line Therapies in Multiple Myeloma

August 20, 2020,

MRD, Biomarkers in Multiple Myeloma

August 17, 2020,

Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma

August 13, 2020,

Exploring Challenges With CAR T Cells and NK Cells in Multiple Myeloma

August 11, 2020,

Upcoming patient seminar: Hamilton

August 11, 2020,

GSK nabs FDA approval for first-in-class multiple myeloma drug

August 7, 2020,

Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma

August 6, 2020,

“Good-Risk” Group of Patients With Myeloma Saw Better Outcomes

August 4, 2020,

Severe Renal Impairment Worsens Outcomes in Multiple Myeloma

August 3, 2020,

Inpatient Mortality With Renal Impairment in Patients With Multiple Myeloma

July 30, 2020,

EU Approval Urged for GSX’s Belantamab Mafodotin for Heavily Treated Myeloma

July 28, 2020

FDA Office Favors Antibody-drug Conjugate for Advanced Multiple Myeloma

July 21, 2020

Upcoming Patient Seminar: Whangarei Myeloma Seminar

July 20, 2020,

Case Report Describes Late-onset MG in Man Treated for Multiple Myeloma

July 20, 2020,

HealthTree® Launches HealthTree University for Multiple Myeloma Patients

July 10, 2020,

FDA Places MELANI-01 Study for Multiple Myeloma on Hold After Safety Report Submission

July 9, 2020,

Dr. Kumar on Stem Cell Mobilization in Multiple Myeloma

July 2, 2020,

Ninlaro Maintenance Therapy Improves Survival in Patients Not Given ASCT, Trial Shows

June 30, 2020

Multiple myeloma triple therapy now on PBS

June 29, 2020

GNS Healthcare Launches In Silico Multiple Myeloma “Patient”

June 26, 2020

MRP a valuable risk assessment tool for newly diagnosed multiple myeloma

June 18, 2020

Dr. Hari on the Role of MRD in Multiple Myeloma

June 16, 2020,

Study Identifies Independent Predictors of Smoldering Multiple Myeloma Progression

June 10, 2020

Article of the week: Daratumumab, Lenalidomide, Bortezomib, & Dexamethasone for Transplant-eligible Newly Diagnosed Multiple Myeloma: GRIFFIN

June 3, 2020,

Multiple Myeloma Research Review

May 29, 2020

Australian clinicians report on real world use of bortezomib in elderly MM patients

May 22, 2020

Article of the week: Once-versus twice-weekly car fi lzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis

May 22, 2020,

Daratumumab and Hyaluronidase-fihj Approved For Patients With Myeloma

May 18, 2020

Cell Protein Analysis May Predict Multiple Myeloma Response to Treatment

May 12, 2020

COVID-19’s Impact on How Patients with CLL, Myeloma Have Received Treatment

May 5, 2020

Newsletter: Autumn 2020

May 4, 2020

Blood cancer patients at most risk from COVID-19 compared to other cancers

April 28, 2020

Spain Reviewing Trial to Treat COVID-19 Pneumonia With Myeloma Therapy Aplidin

April 24, 2020

Genetic Test Could Determine Patients With Ultra High Risk Multiple Myeloma

April 21, 2020